Advancing Pain Understanding and Drug Discovery: Insights from Preclinical Models and Recent Research Findings
Pharmaceuticals · 28.10.2024 · 17 (11) · 1439
DOI: 10.3390/ph17111439 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 28.10.2024. Verfasst von Yahya I Asiri und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, College of Pharmacy, King Khalid University, Abha 62521, Saudi Arabia. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 322 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Khalid University.
Abstract (Originalsprache)
Despite major advancements in our understanding of its fundamental causes, pain—both acute and chronic—remains a serious health concern. Various preclinical investigations utilizing diverse animal, cellular, and alternative models are required and frequently demanded by regulatory approval bodies to bridge the gap between the lab and the clinic. Investigating naturally occurring painful disorders can speed up medication development at the preclinical and clinical levels by illuminating molecular pathways. A wide range of animal models related to pain have been developed to elucidate pathophysiological mechanisms and aid in identifying novel targets for treatment. Pain sometimes drugs fail clinically, causing high translational costs due to poor selection and the use of preclinical tools and reporting. To improve the study of pain in a clinical context, researchers have been creating innovative models over the past few decades that better represent pathological pain conditions. In this paper, we provide a summary of traditional animal models, including rodents, cellular models, human volunteers, and alternative models, as well as the specific characteristics of pain diseases they model. However, a more rigorous approach to preclinical research and cutting-edge analgesic technologies may be necessary to successfully create novel analgesics. The research highlights from this review emphasize new opportunities to develop research that includes animals and non-animals using proven methods pertinent to comprehending and treating human suffering. This review highlights the value of using a variety of modern pain models in animals before human trials. These models can help us understand the different mechanisms behind various pain types. This will ultimately lead to the development of more effective pain medications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, College of Pharmacy, King Khalid University, Abha 62521, Saudi Arabia.
- Health Research Centre, Jazan University, Jazan 45142, Saudi Arabia.
- Department of Pharmaceutics, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia.
- Department of Pharmaceutical Sciences, UConn School of Pharmacy, University of Connecticut, Storrs, CT 06269, USA.
ORCID-Profile: Sivakumar S Moni, Mohankumar Ramar, Kumarappan Chidambaram
Förderung
- King Khalid University
Zitieren
APA
Asiri, Y. I., Moni, S. S., Ramar, M., & Chidambaram, K. (2024). Advancing Pain Understanding and Drug Discovery: Insights from Preclinical Models and Recent Research Findings. Pharmaceuticals, 17(11), 1439. https://doi.org/10.3390/ph17111439
Vancouver
Asiri YI, Moni SS, Ramar M, Chidambaram K. Advancing Pain Understanding and Drug Discovery: Insights from Preclinical Models and Recent Research Findings. Pharmaceuticals. 2024;17(11):1439. doi:10.3390/ph17111439
BibTeX
@article{Asiri2024,
author = {Asiri, Yahya I and Moni, Sivakumar S and Ramar, Mohankumar and Chidambaram, Kumarappan},
title = {Advancing Pain Understanding and Drug Discovery: Insights from Preclinical Models and Recent Research Findings},
journal = {Pharmaceuticals},
year = {2024},
volume = {17},
number = {11},
pages = {1439},
doi = {10.3390/ph17111439}
}
EUVIMED